Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1984 1
1988 4
1990 2
1992 2
1993 1
1994 2
1995 1
1996 2
1997 4
1998 1
1999 1
2000 3
2001 4
2002 3
2003 5
2004 8
2005 6
2006 11
2007 7
2008 3
2009 9
2010 10
2011 12
2012 13
2013 16
2014 9
2015 19
2016 28
2017 32
2018 48
2019 73
2020 107
2021 81
Text availability
Article attribute
Article type
Publication date

Search Results

464 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol Adverse Effects and Toxicity.
Huestis MA, Solimini R, Pichini S, Pacifici R, Carlier J, Busardò FP. Huestis MA, et al. Curr Neuropharmacol. 2019;17(10):974-989. doi: 10.2174/1570159X17666190603171901. Curr Neuropharmacol. 2019. PMID: 31161980 Free PMC article. Review.
Studies defining CBD's beneficial effects were included to provide balance in estimating risk/benefit. ...Human CBD studies for epilepsy and psychiatric disorders reported CBD-induced drug-drug interactions, hepatic abnormalities, diarrhea, fatigue, vo …
Studies defining CBD's beneficial effects were included to provide balance in estimating risk/benefit. ...Human CBD stu …
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
Burstein S. Burstein S. Bioorg Med Chem. 2015 Apr 1;23(7):1377-85. doi: 10.1016/j.bmc.2015.01.059. Epub 2015 Feb 7. Bioorg Med Chem. 2015. PMID: 25703248 Review.
This was no doubt due to the belief that activity meant psychoactivity that was shown by THC and not by CBD. In retrospect this must be seen as unfortunate since a number of actions of CBD with potential therapeutic benefit were downplayed for many years. In …
This was no doubt due to the belief that activity meant psychoactivity that was shown by THC and not by CBD. In retrospect this must …
Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis.
Pamplona FA, da Silva LR, Coan AC. Pamplona FA, et al. Front Neurol. 2018 Sep 12;9:759. doi: 10.3389/fneur.2018.00759. eCollection 2018. Front Neurol. 2018. PMID: 30258398 Free PMC article.

Patients treated with CBD-rich extracts reported lower average dose (6.0 mg/kg/day) [DOSAGE ERROR CORRECTED] than those using purified CBD (25.3 mg/kg/day). [DOSAGE ERROR CORRECTED] The reports of mild (158/216 76% vs. 148/447, 33% p < 0.001) and severe (41/155,

Patients treated with CBD-rich extracts reported lower average dose (6.0 mg/kg/day) [DOSAGE ERROR CORRECTED] than those using purifie …
Review of the neurological benefits of phytocannabinoids.
Maroon J, Bost J. Maroon J, et al. Surg Neurol Int. 2018 Apr 26;9:91. doi: 10.4103/sni.sni_45_18. eCollection 2018. Surg Neurol Int. 2018. PMID: 29770251 Free PMC article. Review.
CBD and delta9-THC interact uniquely with the endocannabinoid system (ECS). ...CONCLUSIONS: In this review we will provide animal and human research data on the current clinical neurological uses for CBD individually and in combination with delta9-THC. We will empha
CBD and delta9-THC interact uniquely with the endocannabinoid system (ECS). ...CONCLUSIONS: In this review we will provide animal and
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
White CM. White CM. J Clin Pharmacol. 2019 Jul;59(7):923-934. doi: 10.1002/jcph.1387. Epub 2019 Feb 7. J Clin Pharmacol. 2019. PMID: 30730563 Review.
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. ...The control of refractory seizures is a clear exception, with strong evidence of CBD's benefit. Acute CBD dosing before anxiety-provoking events like publ …
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. ...The control of refractory seizures …
Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders.
Baswan SM, Klosner AE, Glynn K, Rajgopal A, Malik K, Yim S, Stern N. Baswan SM, et al. Clin Cosmet Investig Dermatol. 2020 Dec 8;13:927-942. doi: 10.2147/CCID.S286411. eCollection 2020. Clin Cosmet Investig Dermatol. 2020. PMID: 33335413 Free PMC article. Review.
Though there is limited research confirming the purported topical benefits of cannabinoids, it is certain that cutaneous biology is modulated by the human endocannabinoid system (ECS). ...This article provides an update on the advances in CBD research to date and th …
Though there is limited research confirming the purported topical benefits of cannabinoids, it is certain that cutaneous biology is m …
The pharmacokinetics and the pharmacodynamics of cannabinoids.
Lucas CJ, Galettis P, Schneider J. Lucas CJ, et al. Br J Clin Pharmacol. 2018 Nov;84(11):2477-2482. doi: 10.1111/bcp.13710. Epub 2018 Aug 7. Br J Clin Pharmacol. 2018. PMID: 30001569 Free PMC article. Review.
An important example is the CBD-mediated inhibition of clobazam metabolism. Pharmacodynamic interactions may occur if cannabis is administered with other central nervous system depressant drugs, and cardiac toxicity may occur via additive hypertension and tachycardia with …
An important example is the CBD-mediated inhibition of clobazam metabolism. Pharmacodynamic interactions may occur if cannabis is adm …
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease.
Watt G, Karl T. Watt G, et al. Front Pharmacol. 2017 Feb 3;8:20. doi: 10.3389/fphar.2017.00020. eCollection 2017. Front Pharmacol. 2017. PMID: 28217094 Free PMC article. Review.
Interestingly, combination therapies of CBD and delta(9)-tetrahydrocannabinol (THC), the main active ingredient of cannabis sativa, show that CBD can antagonize the psychoactive effects associated with THC and possibly mediate greater therapeutic benefits tha …
Interestingly, combination therapies of CBD and delta(9)-tetrahydrocannabinol (THC), the main active ingredient of cannabis sativa, s …
Cannabidiol in Anxiety and Sleep: A Large Case Series.
Shannon S, Lewis N, Lee H, Hughes S. Shannon S, et al. Perm J. 2019;23:18-041. doi: 10.7812/TPP/18-041. Perm J. 2019. PMID: 30624194 Free PMC article.
Evidence points toward a calming effect for CBD in the central nervous system. Interest in CBD as a treatment of a wide range of disorders has exploded, yet few clinical studies of CBD exist in the psychiatric literature. ...Sleep scores improved within the f …
Evidence points toward a calming effect for CBD in the central nervous system. Interest in CBD as a treatment of a wide range …
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
Baron EP. Baron EP. Headache. 2018 Jul;58(7):1139-1186. doi: 10.1111/head.13345. Headache. 2018. PMID: 30152161 Review.
Most of the existing literature reports on the cannabinoids delta(9) -tetrahydrocannabinol (THC) and cannabidiol (CBD), or cannabis in general. There are many cannabis strains that vary widely in the composition of cannabinoids, terpenes, flavonoids, and other compounds. . …
Most of the existing literature reports on the cannabinoids delta(9) -tetrahydrocannabinol (THC) and cannabidiol (CBD), or cannabis i …
464 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page